<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BMC Geriatrics - Latest articles</title>
		<link>http://www.biomedcentral.com/bmcgeriatr/</link>
		<description>The latest articles from BMC Geriatrics (ISSN 1471-2318) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/8/16"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/8/15"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/8/14"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/8/13"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/8/12"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/8/11"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/8/10"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/8/9"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/8/8"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/8/7"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.biomedcentral.com/1471-2318/8/16">
            
            <title>The MOBILIZE Boston Study: Design and methods of a prospective cohort study of novel risk factors for falls in an older population</title>
			<description>Background:
Falls are the sixth leading cause of death in elderly people in the U.S.  Despite progress in understanding risk factors for falls, many suspected risk factors have not been adequately studied.  Putative risk factors for falls such as pain, reductions in cerebral blood flow, somatosensory deficits, and foot disorders are poorly understood, in part because they pose measurement challenges, particularly for large observational studies.  
Methods:
The MOBILIZE Boston Study (MBS), an NIA-funded Program Project, is a prospective cohort study of a unique set of risk factors for falls in seniors in the Boston area.  Using a door-to-door population-based recruitment, we have enrolled 765 persons aged 70 and older.  The baseline assessment was conducted in 2 segments: a 3-hour home interview followed within 4 weeks by a 3-hour clinic examination.  Measures included pain, cerebral hemodynamics, and foot disorders as well as established fall risk factors.  For the falls follow-up, participants return fall calendar postcards to the research center at the end of each month.  Reports of falls are followed-up with a telephone interview to assess circumstances and consequences of each fall.  A second assessment is performed 18 months following baseline. 
Results:
Of the 2382 who met all eligibility criteria at the door, 1616 (67.8%) agreed to participate and were referred to the research center for further screening.  The primary reason for ineligibility was inability to communicate in English.  Results from the first 600 participants showed that participants are largely representative of seniors in the Boston area in terms of age, sex, race and Hispanic ethnicity.  The average age of study participants was 77.9 years (s.d. 5.5) and nearly two-thirds were women.  The study cohort was 78% white and 17% black.  Many participants (39%) reported having fallen at least once in the year before baseline.  
Conclusions:
Our results demonstrate the feasibility of conducting comprehensive assessments, including rigorous physiologic measurements, in a diverse population of older adults to study non-traditional risk factors for falls and disability.  The MBS will provide an important new data resource for examining novel risk factors for falls and mobility problems in the older population.</description>
			<link>http://www.biomedcentral.com/1471-2318/8/16</link>
			
			 	<dc:creator>Suzanne G Leveille, Douglas P Kiel, Richard N Jones, Anthony Roman, Marian T Hannan, Farzeneh A Sorond, Hyun G Kang, Elizabeth J Samelson, Margaret Gagnon, Marcie Freeman and Lewis A Lipsitz</dc:creator>
			
			<dc:source>BMC Geriatrics 2008, 8:16</dc:source>
			<dc:date>2008-07-18</dc:date>
			<dc:identifier>doi:10.1186/1471-2318-8-16</dc:identifier>
			
			
							
					<prism:publicationName>BMC Geriatrics</prism:publicationName>
					
			
							
					<prism:issn>1471-2318</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>16</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-18</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2318/8/15">
            
            <title>Use of computerized dynamic posturography to assess balance in older adults after nighttime awakenings using zolpidem as a reference</title>
			<description>Background:
Computerized dynamic posturography (CDP) has been used to detect balance and stability impairments in adults of all ages. The goal of the current pilot study was to evaluate balance in healthy older adults after a middle-of-the-night awakening and to assess the ability of CDP to measure effects of bedtime zolpidem administration. 
Methods:
Two studies used CDP to evaluate balance in healthy older adults (>65 years) during middle-of-the-night awakenings. The first study used a drug-free, single-period, within-subject, repeated measures study design. Subjects were evaluated during the day, pre-sleep, and 2 hours after bedtime for dynamic standing balance using the NeuroCom EquiTest Sensory Organization Test (SOT). Pairwise comparisons were made using one-way ANOVA. The second study was a single-blind, randomized, placebo-controlled, crossover study evaluating the ability of the SOT to measure medication-induced dynamic standing balance impairments using the commonly prescribed sleep medication, zolpidem 10 mg as a test medication. Assessments were performed at night before zolpidem administration and then again 2 hours after bedtime. Comparisons were made between the 2 groups using an ANCOVA model.
Results:
Twelve older adults (mean age 68.4 years) were evaluated in the first study. There was no significant difference between pre-sleep and middle-of-the-night assessments for the SOT composite score (P=0.439). Eleven older adults (mean age 68.9 years) were evaluated in the second study. Zolpidem administration significantly decreased the SOT composite score after a middle-of-the-night awakening compared with placebo (P&lt;0.001). 
Conclusions:
In healthy older adults, getting up in the middle of the night did not have a significant effect on dynamic standing balance; however, bedtime administration of zolpidem 10 mg did lead to significant impairments. Thus, the SOT was able to measure medication-induced dynamic standing balance impairments and may be useful for future studies comparing balance effects of medications.</description>
			<link>http://www.biomedcentral.com/1471-2318/8/15</link>
			
			 	<dc:creator>Gary Zammit, Sherry Wang-Weigand and Xuejun Peng</dc:creator>
			
			<dc:source>BMC Geriatrics 2008, 8:15</dc:source>
			<dc:date>2008-07-15</dc:date>
			<dc:identifier>doi:10.1186/1471-2318-8-15</dc:identifier>
			
			
							
					<prism:publicationName>BMC Geriatrics</prism:publicationName>
					
			
							
					<prism:issn>1471-2318</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>15</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-15</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2318/8/14">
            
            <title>The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample</title>
			<description>Background:
While the evidence of an association between the apolipoprotein E (APOE) *E4 allele and Alzheimer's disease is very strong, the effect of the *E4 allele on cognitive decline in the general population is more equivocal. A cross-sectional study on the lifespan effects of the *E4 allele [1] failed to find any effect of the *E4 allele on cognitive performance at ages 20-24, 40-44 or 60-64 years. 
Methods:
In this four year follow-up study, we reexamine the effect of *E4 in the sample of 2,021 individuals, now aged 65-69 years. 
Results:
Performance on the Mini-Mental State Examination (MMSE) was significantly poorer for *E4 homozygotes than heterozygotes or non-carriers. The effects of the *E4 genotype on cognitive decline over four years were found on the MMSE and Symbol-Digit Modalities test but only when controlling for risk factors such as head injury and education. Analyses were repeated with the exclusion of participants diagnosed with a mild cognitive disorder, with little change. 
Conclusions:
It is possible that *E4 carriers become vulnerable to greater cognitive decline in the presence of other risk factors at 65-69 years of age.</description>
			<link>http://www.biomedcentral.com/1471-2318/8/14</link>
			
			 	<dc:creator>Helen Christensen, Philip J Batterham, Andrew J Mackinnon, Anthony F Jorm, Holly A Mack, Karen A Mather, Kaarin J Anstey, Perminder S Sachdev and Simon Easteal</dc:creator>
			
			<dc:source>BMC Geriatrics 2008, 8:14</dc:source>
			<dc:date>2008-07-14</dc:date>
			<dc:identifier>doi:10.1186/1471-2318-8-14</dc:identifier>
			
			
							
					<prism:publicationName>BMC Geriatrics</prism:publicationName>
					
			
							
					<prism:issn>1471-2318</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>14</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-14</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2318/8/13">
            
            <title>Quality of anticoagulation and use of warfarin-interacting medications in long-term care: A chart review</title>
			<description>Background:
Maintenance of therapeutic International Normalized Ratio (INR) in the community is generally poor. The supervised environment in long-term care facilities may represent a more ideal setting for warfarin therapy since laboratory monitoring, compliance, dose adjustment, and interacting medications can all be monitored and controlled. The objectives of this study were to determine how effectively warfarin was administered to a cohort of residents in long-term care facilities, to identify the proportion of residents prescribed warfarin-interacting drugs and to ascertain factors associated with poor INR control.
Methods:
A chart review of 105 residents receiving warfarin therapy in five long-term care facilities in Hamilton, Ontario was performed. Data were collected on INR levels, warfarin prescribing and monitoring practices, and use of interacting medications.
Results:
Over a 12 month period (28,555 resident-days, 78.2 resident years) 3065 INR values were available. Residents were within, below and above the therapeutic range 54%, 35% and 11% of the time, respectively. Seventy-nine percent of residents were prescribed at least one warfarin-interacting medication during the period in review. Residents receiving interacting medications spent less time in the therapeutic range (53.0% vs. 58.2%, OR = 0.93, 95% confidence interval 0.88 to 0.97, P = 0.002). Adequacy of anticoagulation varied significantly between physicians (time in therapeutic range 45.9 to 63.9%).
Conclusion:
In this group of long-term care residents, warfarin control was suboptimal. Both prescriber and co-prescription of interacting medications were associated with poorer INR control. Future studies should seek strategies to improve prescriber skill and decrease use of interacting medications.</description>
			<link>http://www.biomedcentral.com/1471-2318/8/13</link>
			
			 	<dc:creator>Madeleine Verhovsek, Bahareh Motlagh, Mark A Crowther, Courtney Kennedy, Lisa Dolovich, Glenda Campbell, Luqi Wang and Alexandra Papaioannou</dc:creator>
			
			<dc:source>BMC Geriatrics 2008, 8:13</dc:source>
			<dc:date>2008-07-03</dc:date>
			<dc:identifier>doi:10.1186/1471-2318-8-13</dc:identifier>
			
			
							
					<prism:publicationName>BMC Geriatrics</prism:publicationName>
					
			
							
					<prism:issn>1471-2318</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>13</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-03</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2318/8/12">
            
            <title>DeLLITE Depression in late life: an intervention trial of exercise. Design and recruitment of a randomised controlled trial</title>
			<description>Background:
Physical activity shows potential in combating the poor outcomes associated with depression in older people. Meta-analyses show gaps in the research with poor trial design compromising certainty in conclusions and few programmes showing sustained effects.Methods/designThe Depression in Late Life: an Intervention Trial of Exercise (DeLLITE) is a 12 month randomised controlled trial of a physical activity intervention to increase functional status in people aged 75 years and older with depressive symptoms. The intervention involves an individualised activity programme based on goal setting and progression of difficulty of activities delivered by a trained nurse during 8 home visits over 6 months. The control group received time matched home visits to discuss social contacts and networks. Baseline, 6 and 12 months measures were assessed in face to face visits with the primary outcome being functional status (SPPB, NEADL). Secondary outcomes include depressive symptoms (Geriatric Depression Scale), quality of life (SF-36), physical activity (AHS Physical Activity Questionnaire) and falls (self report).DiscussionDue to report in 2008 the DeLLITE study has recruited 70% of those eligible and tests the efficacy of a home based, goal setting physical activity programme in improving function, mood and quality of life in older people with depressive symptomatology. If successful in improving function and mood this trial could prove for the first time that there are long term health benefit of physical activity, independent of social activity, in this high risk group who consume excess health related costs.Trial registrationAustralian and New Zealand Clinical Trials Register ACTRN12605000475640</description>
			<link>http://www.biomedcentral.com/1471-2318/8/12</link>
			
			 	<dc:creator>Ngaire Kerse, Karen Falloon, Simon A Moyes, Karen J Hayman, Tony Dowell, Gregory S Kolt, C Raina Elley, Simon Hatcher, Kathy Peri, Sally Keeling, Elizabeth Robinson, John Parsons, Janine Wiles and Bruce Arroll</dc:creator>
			
			<dc:source>BMC Geriatrics 2008, 8:12</dc:source>
			<dc:date>2008-05-24</dc:date>
			<dc:identifier>doi:10.1186/1471-2318-8-12</dc:identifier>
			
			
							
					<prism:publicationName>BMC Geriatrics</prism:publicationName>
					
			
							
					<prism:issn>1471-2318</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>12</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-24</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2318/8/11">
            
            <title>Influenza and pneumococcal vaccine uptake among nursing home residents in Nottingham, England: a postal questionnaire survey</title>
			<description>Background:
Previous studies have shown influenza vaccine uptake in UK nursing home residents to be low. Very little information exists regarding the uptake of pneumococcal vaccine in this population. The formulation of policies relating to the vaccination of residents has been proposed as a simple step that may help improve vaccine uptake in care homes.
Methods:
A postal questionnaire was sent to matrons of all care homes with nursing within the Greater Nottingham area in January 2006. Non respondents were followed up with up to 3 phone calls.
Results:
30% (16/53) of respondents reported having a policy addressing influenza vaccination and 15% (8/53) had a policy addressing pneumococcal vaccination. Seasonal influenza vaccine coverage in care homes with a vaccination policy was 87% compared with 84% in care homes without a policy (p = 0.47). The uptake of pneumococcal vaccination was found to be low, particularly in care homes with no vaccination policy. Coverage was 60% and 32% in care homes with and without a vaccination policy respectively (p = 0.06). This result was found to be statistically significant on multivariate analysis (p = 0.03, R = 0.46)
Conclusion:
The uptake of influenza vaccine among care home residents in the Nottingham region is relatively high, although pneumococcal vaccine uptake is low. This study shows that there is an association between pneumococcal vaccine uptake and the existence of a vaccination policy in care homes, and highlights that few care homes have vaccination policies in place.</description>
			<link>http://www.biomedcentral.com/1471-2318/8/11</link>
			
			 	<dc:creator>Amir Shroufi, Joanna Copping, Roberto Vivancos and Richard CB Slack</dc:creator>
			
			<dc:source>BMC Geriatrics 2008, 8:11</dc:source>
			<dc:date>2008-05-16</dc:date>
			<dc:identifier>doi:10.1186/1471-2318-8-11</dc:identifier>
			
			
							
					<prism:publicationName>BMC Geriatrics</prism:publicationName>
					
			
							
					<prism:issn>1471-2318</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>11</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-16</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2318/8/10">
            
            <title>Adverse outcomes following hospitalization in acutely ill older patients</title>
			<description>Background:
The longitudinal outcomes of patients admitted to acute care for elders units (ACE) are mixed. We studied the associations between socio-demographic and functional measures with hospital length of stay (LOS), and which variables predicted adverse events (non-independent living, readmission, death) 3 and 6 months later.
Methods:
Prospective cohort study of community-living, medical patients age 75 or over admitted to ACE at a teaching hospital.
Results:
The population included 147 subjects, median LOS of 9 days (interquartile range 5&#8211;15 days). All returned home/community after hospitalization. Just prior to discharge, baseline timed up and go test (TUG, P &lt; 0.001), bipedal stance balance (P = 0.001), and clinical frailty scale scores (P = 0.02) predicted LOS, with TUG as the only independent predictor (P &lt; 0.001) in multiple regression analysis. By 3 months, 59.9% of subjects remained free of an adverse event, and by 6 months, 49.0% were event free. The 3 and 6-month mortality was 10.2% and 12.9% respectively. Almost one-third of subjects had developed an adverse event by 6 months, with the highest risk within the first 3 months post discharge. An abnormal TUG score was associated with increased adjusted hazard ratio [HR] 1.28, 95% confidence interval [CI] 1.03 to 1.59, P = 0.03. A higher FMMSE score (adjusted HR 0.89, 95% CI 0.82 to 0.96, P = 0.003) and independent living before hospitalization (adjusted HR 0.42, 95% CI 0.21 to 0.84, P = 0.01) were associated with reduced risk of adverse outcome.
Conclusion:
Some ACE patients demonstrate further functional decline following hospitalization, resulting in loss of independence, repeat hospitalization, or death. Abnormal TUG is associated with prolonged LOS and future adverse outcomes.</description>
			<link>http://www.biomedcentral.com/1471-2318/8/10</link>
			
			 	<dc:creator>Roger Y Wong and William C Miller</dc:creator>
			
			<dc:source>BMC Geriatrics 2008, 8:10</dc:source>
			<dc:date>2008-05-14</dc:date>
			<dc:identifier>doi:10.1186/1471-2318-8-10</dc:identifier>
			
			
							
					<prism:publicationName>BMC Geriatrics</prism:publicationName>
					
			
							
					<prism:issn>1471-2318</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>10</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-14</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2318/8/9">
            
            <title>How do older patients and their GPs evaluate shared decision-making in healthcare?</title>
			<description>Background:
Older persons represent a growing share of the population, yet very little is known about their specific healthcare needs, problems, and expectations. IMPROVE is an international research project that seeks to improve elderly persons' involvement in their healthcare. This paper analyzes perceptions of patient involvement by elderly patients and their GPs in family medicine in Slovenia.
Methods:
Semi-structured interviews with patients over 70 and their GPs were audio-taped and transcribed. The interviews were analyzed using qualitative content analysis.
Results:
Specific characteristics of old age must be taken into account in the involvement of older patients. It is important to know the patient's expectations and to communicate clearly with the patient. A trusting relationship between the GP and the patient is a prerequisite for involvement. GPs center involvement on the GP's side. Involvement of the elderly is linked to ethical dilemmas.
Conclusion:
Understanding the involvement of the elderly focuses more on building a relationship than on making decisions. It is reasonable to educate GPs and GPs' coworkers about caring relationships. Ethical aspects have often been treated in a theoretical manner, whereas empirical practice may be entirely different from theoretical premises. GPs and older patients must learn more about how to address their ethical dilemmas.</description>
			<link>http://www.biomedcentral.com/1471-2318/8/9</link>
			
			 	<dc:creator>Danica Rotar-Pavli&#269;, Igor &#352;vab and Raymond Wetzels</dc:creator>
			
			<dc:source>BMC Geriatrics 2008, 8:9</dc:source>
			<dc:date>2008-05-01</dc:date>
			<dc:identifier>doi:10.1186/1471-2318-8-9</dc:identifier>
			
			
							
					<prism:publicationName>BMC Geriatrics</prism:publicationName>
					
			
							
					<prism:issn>1471-2318</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>9</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-01</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2318/8/8">
            
            <title>Assessing control of postural stability in community-living older adults using performance-based limits of stability</title>
			<description>Background:
Balance disability measurements routinely used to identify fall risks in frail populations have limited value in the early detection of postural stability deficits in community-living older adults. The objectives of the study were to 1) measure performance-based limits of stability (LOS) in community-living older adults and compare them to theoretical LOS computed from data proposed by the Balance Master&#174; system, 2) explore the feasibility of a new measurement approach based on the assessment of postural stability during weight-shifting tasks at performance-based LOS, 3) quantify intra-session performance variability during multiple trials using the performance-based LOS paradigm.
Methods:
Twenty-four healthy community-living older adults (10 men, 14 women) aged between 62 to 85 (mean age &#177; sd, 71.5 &#177; 6 yrs) participated in the study. Subjects' performance-based LOS were established by asking them to transfer their body weight as far as possible in three directions (forward, right and left) without changing their base of support. LOS were computed as the maximal excursion of the COP in each direction among three trials. Participants then performed two experimental tasks that consisted in controlling, with the assistance of visual feedback, their centre of pressure (COP) within two predefined targets set at 100% of their performance-based LOS. For each tasks 8 trials were performed. Ground reaction forces and torques during performance-based LOS evaluation and experimental tasks were recorded with a force plate. Sway area and medio-lateral mean COP displacement speed variables were extracted from force plate recordings.
Results:
Significant differences between theoretical LOS computed from maximum leaning angles derived from anthropometric characteristics and performance-based LOS were observed. Results showed that a motor learning effect was present as the participants optimized their weight-shifting strategy through the first three trials of each task using the visual biofeedback provided on their COP. Reliable measures of control of postural stability at performance-based LOS can be obtained after two additional trials after the learning phase (0.69 > ICC > 1.0).
Conclusion:
Establishing performance-based LOS instead of relying on estimations of theoretical LOS offers a more individualized and realistic insight on the true LOS of an individual. Performance-based LOS can be used as targets during weight-shifting postural tasks with real time visual feedback of the COP displacement to assess postural stability of community-living older adults. In order to obtain reliable results, a learning phase allowing subjects to learn how to control their COP displacement is needed.</description>
			<link>http://www.biomedcentral.com/1471-2318/8/8</link>
			
			 	<dc:creator>Myriam Jbabdi, Patrick Boissy and Mathieu Hamel</dc:creator>
			
			<dc:source>BMC Geriatrics 2008, 8:8</dc:source>
			<dc:date>2008-03-31</dc:date>
			<dc:identifier>doi:10.1186/1471-2318-8-8</dc:identifier>
			
			
							
					<prism:publicationName>BMC Geriatrics</prism:publicationName>
					
			
							
					<prism:issn>1471-2318</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>8</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-31</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2318/8/7">
            
            <title>The use of advanced tracking technologies for the analysis of mobility in Alzheimer's disease and related cognitive diseases</title>
			<description>Background:
One of the more common behavioral manifestations of dementia-related disorders is severe problems with out-of-home mobility. Various efforts have been attempted to attain a better understanding of mobility behavior, but most studies are based on institutionalized patients and the assessment usually relies on reports of caregivers and institutional staff, using observational approaches, activity monitoring, or behavioral checklists. The current manuscript describes the research protocol of a project that measures mobility in Alzheimer's disease and related cognitive disorders in an innovative way, by taking advantage of advanced tracking technologies.Methods/designParticipants are 360 demented persons, mildly cognitively impaired persons, and unimpaired controls aged &#8805; 65 in Israel and Germany. Data regarding space-time activities will be collected via a GPS tracking kit for a period of 4 weeks in 3 waves (one year apart) with the same participants (using a repeated measures design). Participants will be interviewed by use of a battery of instruments prior to and following GPS data collection. Further, a family member will complete a questionnaire both before and after data tracking.Statistical analyses will strive to explain differences in mobility based on a wide range of socio-structural, clinical, affect-related and environmental variables. We will also assess the impact of the use of advanced tracking technology on the quality of life of dementia patients and care givers, as well as its potential as a diagnostic tool. Systematic assessment of ethical issues involved in the use of tracking technology will be an integral component of the project.DiscussionThis project will be able to make a substantial contribution to basic as well as applied and clinical aspects in the area of mobility and cognitive impairment research. The innovative technologies applied in this study will allow for assessing a range of dimensions of out-of-home mobility, and provide better quality data.</description>
			<link>http://www.biomedcentral.com/1471-2318/8/7</link>
			
			 	<dc:creator>Noam Shoval, Gail K Auslander, Tim Freytag, Ruth Landau, Frank Oswald, Ulrich Seidl, Hans-Werner Wahl, Shirli Werner and Jeremia Heinik</dc:creator>
			
			<dc:source>BMC Geriatrics 2008, 8:7</dc:source>
			<dc:date>2008-03-26</dc:date>
			<dc:identifier>doi:10.1186/1471-2318-8-7</dc:identifier>
			
			
							
					<prism:publicationName>BMC Geriatrics</prism:publicationName>
					
			
							
					<prism:issn>1471-2318</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>7</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-26</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
